Strain identifier

BacDive ID: 136316

Type strain: No

Species: Rhodococcus rhodochrous

Strain history: CIP <- 1995, PCM <- IC: strain 1581, Mycobacterium rhodochrous

NCBI tax ID(s): 1829 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 9 (current version):
version 8.1:
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 9 (current version)

General

@ref: 35687

BacDive-ID: 136316

description: Rhodococcus rhodochrous CIP 104635 is a prokaryote.

NCBI tax id

  • NCBI tax id: 1829
  • Matching level: species

strain history

  • @ref: 35687
  • history: CIP <- 1995, PCM <- IC: strain 1581, Mycobacterium rhodochrous

doi: 10.13145/bacdive136316.20240510.9

Name and taxonomic classification

LPSN

  • @ref: 20215
  • genus: Rhodococcus
  • species: Rhodococcus rhodochrous
  • full scientific name: Rhodococcus rhodochrous (Zopf 1891) Tsukamura 1974 (Approved Lists 1980)
  • synonyms

    @refsynonym
    20215Staphylococcus rhodochrous
    20215Rhodococcus roseus

@ref: 35687

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Mycobacteriales

family: Nocardiaceae

genus: Rhodococcus

species: Rhodococcus rhodochrous

type strain: no

Culture and growth conditions

culture medium

@refnamegrowthcompositionlink
35687MEDIUM 3 - Columbia agaryesColumbia agar (39.000 g);distilled water (1000.000 ml)
35687CIP Medium 3yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=3

culture temp

  • @ref: 35687
  • growth: positive
  • type: growth
  • temperature: 30

Safety information

risk assessment

  • @ref: 35687
  • biosafety level: 1
  • biosafety level comment: Risk group (French classification)

External links

@ref: 35687

culture collection no.: CIP 104635, PCM 909

straininfo link

  • @ref: 93494
  • straininfo: 69899

literature

  • topic: Metabolism
  • Pubmed-ID: 16243323
  • title: Chemical and biochemical transformations of 5-ethoxycarbonyl-5-phenyl-2-isoxazolines.
  • authors: Zadrozna I, Kurkowska J, Kruszewska H
  • journal: Farmaco
  • DOI: 10.1016/j.farmac.2005.07.003
  • year: 2005
  • mesh: Anti-Infective Agents/chemistry/*metabolism, Biotransformation, Candida albicans/drug effects/growth & development, Cinnamates/chemistry, Cyanides/chemistry, Escherichia coli/drug effects/growth & development, Heterocyclic Compounds/chemistry/*metabolism, Hydrolysis, Isoxazoles/chemistry/*metabolism, Nitriles/chemistry, Oxidation-Reduction, Rhodococcus/*metabolism, Staphylococcus aureus/drug effects/growth & development, Structure-Activity Relationship
  • topic2: Pathogenicity

Reference

@idauthorstitledoi/urlcatalogue
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ10.1099/ijsem.0.004332
35687Curators of the CIPhttps://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%20104635Collection of Institut Pasteur (CIP 104635)
93494Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.StrainInfo: A central database for resolving microbial strain identifiers10.60712/SI-ID69899.1